Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:
“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:
- CAC Score for risk
- LDL-C cutoffs for LLL initiation
- Bempedoic acid and Evinacumab
- Lp(a) ≥50 mg/dL as a cutoff
- Intensification of LLM post-ACS
- EPA only
- Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
- Dietary supplements”
Stay updated with Hemostasis Today.
Bempedoic Acid
CAC Score
Cardiotoxicity
cardiovascular risk
Dietary Supplements
Dyslipidemia Guidelines
EPA
ESC 2025
European Atherosclerosis Society
Evinacumab
Familial Chylomicronemia Syndrome
Health
Hematology
Hemostasis Today
HIV
LDL Cholesterol
Lipid Lowering Therapy
Lipoprotein a
Medicine
Post ACS Management
statins
Volanesorsen
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?